Should treatment of ALK-positive anaplastic large cell lymphoma be stratified according to minimal residual disease?
Rigaud C, Abbas R, Grand D, Minard-Colin V, Aladjidi N, Buchbinder N, Garnier N, Plat G, Couec ML, Duplan M, Lambilliotte A, Schmitt C, Leblanc T, Lamant L, Brugières L.
Rigaud C, et al.
Pediatr Blood Cancer. 2021 Jun;68(6):e28982. doi: 10.1002/pbc.28982. Epub 2021 Mar 9.
Pediatr Blood Cancer. 2021.
PMID: 33687135